Tag: audio webcast

Strong, broad-based performance across top-line, profitability and cash flow
FY 25 outlook raised

PRESS RELEASE

Amsterdam, July 30, 2025

Net income available to common stockholders of $5.5 million and $48.0 million for the three and six months ended June 30, 2025, respectively, or $0.09 and $0.79 per diluted share, respectively.

BEVERLY, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- ATN International, Inc. (“ATN” or the “Company”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, announced today a change to the start time of its upcoming second quarter 2025 financial results conference call. The call will now begin at 9:00 (ET) on Friday, August 8, 2025, one hour earlier than previously scheduled. All other details remain unchanged.

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI^® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.¹